The retinoblastoma gene: A prototypic and multifunctional tumor suppressor

Experimental Cell Research

Volumn 264, Issue 1, 2001, Pages 2-18

  Zheng, Lei ^a   Lee, Wen Hwa ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; GENE PRODUCT; PROTEIN P53; RETINOBLASTOMA PROTEIN;

CANCER CELL; CARCINOGENESIS; CELL CYCLE; CELL DIFFERENTIATION; CHROMATIN; CHROMOSOME SEGREGATION; GENE MUTATION; GENOME; GERM LINE; KNOCKOUT MOUSE; MITOSIS; MOLECULAR STABILITY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; TUMOR SUPPRESSOR GENE;

ANIMALIA;

EID: 0035835815     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2000.5129     Document Type: Article

References (160)

1. The approaching era of the tumor suppressor genes
2. Molecular genetics of the retinoblastoma suppressor gene
3. Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells
4. The retinoblastoma protein: More than a tumor suppressor
5. Genetic mechanisms of tumor suppression by the human p53 gene
6. Suppression of human colorectal carcinoma cell growth by wild-type p53
7. WT1-mediated growth suppression of Wilms tumor cells expressing a WT1 splicing variant
8. Response of colon cancer cell lines to the introduction of APC, a colon-specific tumor suppressor gene
9. Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain
10. Stability of retinoblastoma gene expression determines the tumorigenicity of reconstituted retinoblastoma cells
11. Adenovirus-mediated retinoblastoma gene therapy suppresses spontaneous pituitary melanotroph tumors in Rb+/- mice
12. RB-mediated suppression of spontaneous multiple neuroendocrine neoplasia and lung metastases in Rb+/- mice
13. The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle
14. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins
15. Cancer cell cycles
16. A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F
17. Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties
18. Molecular cloning of cellular genes encoding retinoblastoma- associated proteins: Identification of a gene with properties of the transcription factor E2F
19. Toward an understanding of the functional complexity of the E2F and retinoblastoma families
20. The regulation of E2F by pRB-family proteins
21. HBP1: A HMG box transcriptional repressor that is targeted by the retinoblastoma family
22. The retinoblastoma protein binds to RIZ, a zinc-finger protein that shares an epitope with the adenovirus EIA protein
23. Cloning and characterization of a novel Kruppel-associated box family transcriptional repressor that interacts with the retinoblastoma gene product
24. The Rb/E2F pathway: Expanding roles and emerging paradigms
25. Expression of transcription factor E2F1 induces quiescent cells to enter S phase
26. Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis
27. Expression of dominant-negative mutant DP-1 blocks cell cycle progression in G1
28. E2F3 is critical for normal cellular proliferation
29. Rb interacts with histone deacetylase to repress transcription
30. Retinoblastoma protein represses transcription by recruiting a histone deacetylase
31. Retinoblastoma protein recruits histone deacetylase to repress transcription
32. RBP1 recruits both histone deacetylase-dependent and -independent repression activities to retinoblastoma family proteins
33. Role of the LXCXE binding site in Rb function
34. A retinoblastoma-binding protein related to a negative regulator of Ras in yeast
35. A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression
36. RB and hbrm cooperate to repress the activation functions of E2F1
37. Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF
38. BRG-1 is required for RB-mediated cell cycle arrest
39. ATP-dependent remodeling and acetylation as regulators of chromatin fluidity
40. Dissecting the regulatory circuitry of a eukaryotic genome
41. The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest
42. Functional interactions between the hBRM/hBRG1 transcriptional activators and the pRB family of proteins
43. Mechanism of transcriptional repression of E2F by the retinoblastoma tumor suppressor protein
44. A mechanism for Rb/p130-mediated transcription repression involving recruitment of the CtBP corepressor
45. Lessons learned from BRCA1 and BRCA2
46. Binding of CtIP to the BRCT repeats of BRCA1 involved in the transcription regulation of p21 is disrupted upon DNA damage
47. C-terminal binding protein is a transcriptional repressor that interacts with a specific class of vertebrate polycomb proteins
48. Ikaros interactions with CtBP reveal a repression mechanism that is independent of histone deacetylase activity
49. The retinoblastoma protein as a fundamental mediator of growth and differentiation signals
50. SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family
51. Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7
52. Establishment of irreversible growth arrest in myogenic differentiation requires the RB LXCXE-binding function
53. Identification of a human homologue of yeast nuc2 which interacts with the retinoblastoma protein in a specific manner
54. Incomplete penetrance of familial retinoblastoma linked to germ-line mutations that result in partial loss of RB function
55. Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth
56. Growth suppression by an E2F-binding-defective retinoblastoma protein (RB): Contribution from the RB C pocket
57. The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity
58. A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle
59. Interaction between the retinoblastoma protein and the oncoprotein MDM2
60. Disruption of retinoblastoma protein function by coexpression of its C pocket fragment
61. Differential regulation of retinoblastoma protein function by specific Cdk phosphorylation sites
62. RB regulates the stability and the apoptotic function of p53 via MDM2
63. The ARF/p53 pathway
64. Mutations of N-terminal regions render the retinoblastoma protein insufficient for functions in development and tumor suppression
65. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis
66. Effects of an Rb mutation in the mouse
67. Dual roles of the retinoblastoma protein in cell cycle regulation and neuron differentiation
68. Expression of a retinoblastoma transgene results in dwarf mice
69. Quantitative effects of the retinoblastoma gene on mouse development and tissue-specific tumorigenesis
70. The amino-terminal region of the retinoblastoma gene product binds a novel nuclear matrix protein that co-localizes to centers for RNA processing
71. A new member of the hsp90 family of molecular chaperones interacts with the retinoblastoma protein during mitosis and after heat shock
72. Detection of a novel cell cycle-regulated kinase activity that associates with the amino terminus of the retinoblastoma protein in G2/M phases
73. The amino terminus of the retinoblastoma (Rb) protein associates with a cyclin-dependent kinase-like kinase via Rb amino acids required for growth suppression
74. Negative regulation of DNA replication by the retinoblastoma protein is mediated by its association with MCM7
75. A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins
76. G1 regulation and checkpoints operating around START in fission yeast
77. Ordering S phase and M phase in the cell cycle
78. Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation
79. Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product
80. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element
81. The retinoblastoma susceptibility gene product undergoes cell cycle-dependent dephosphorylation and binding to and release from SV40 large T
82. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins
83. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4
84. Distinct sub-populations of the retinoblastoma protein show a distinct pattern of phosphorylation
85. Identification of a substrate-targeting domain in cyclin E necessary for phosphorylation of the retinoblastoma protein
86. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes
87. Dual mechanisms for the inhibition of E2F binding to RB by cyclin-dependent kinase-mediated RB phosphorylation
88. Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1
89. Accumulation of cyclin B1 requires E2F and cyclin-A-dependent rearrangement of the anaphase-promoting complex
90. Inhibition of DNA synthesis by RB: Effects on GUS transition and S-phase progression
91. Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function
92. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16
93. Growth suppression by p16ink4 requires functional retinoblastoma protein
94. A cell cycle regulator potentially involved in genesis of many tumor types
95. Inhibitors of mammalian G1 cyclin-dependent kinases
96. CDK inhibitors: Positive and negative regulators of G1-phase progression
97. The murine gene p27Kipl is haplo-insufficient for tumour suppression
98. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
99. p21 is necessary for the p53-mediated G1 arrest in human cancer cells
100. Inhibition of cyclin-dependent kinase 2 by p21 is necessary for retinoblastoma protein-mediated G1 arrest after gamma-irradiation
101. Requirement for a functional Rb-1 gene in murine development
102. Dual roles of the retinoblastoma protein in cell cycle regulation and neuron differentiation
103. Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs
104. Opposing roles of pRB and p107 in adipocyte differentiation
105. Retinoblastoma protein directly interacts with and activates the transcription factor NF-IL6 Proc
106. Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins
107. The helix-loop-helix protein Id-2 enhances cell proliferation and binds to the retinoblastoma protein
108. Id helix-loop-helix proteins in cell growth and differentiation
109. The MyoD family and myogenesis: Redundancy, networks, and thresholds
110. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation
111. The retinoblastoma gene family in differentiation and development
112. +/- mice
113. A thyroid hormone receptor coactivator negatively regulated by the retinoblastoma protein
114. Thyroid hormone, T3-dependent phosphorylation and translocation of trip230 from the golgi complex to the nucleus
115. A role for retinoblastoma protein in potentiating transcriptional activation by the glucocorticoid receptor
116. Rb binds c-Jun and activates transcription
117. Role of the retinoblastoma protein family, pRB, p107 and p130 in the negative control of cell growth
118. Transcriptional repression by the Rb-related protein p107
119. The three members of the pocket proteins family share the ability to repress E2F activity through recruitment of a histone deacetylase
120. Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein
121. p130/pRb2 has growth suppressive properties similar to yet distinctive from those of retinoblastoma family members pRb and p107
122. Transcriptional repression and growth suppression by the p107 pocket protein
123. Interaction of p107 with cyclin A independent of complex formation with viral oncoproteins
124. p107 uses a p21CIP1-related domain to bind cyclin/cdk2 and regulate interactions with E2F
125. Identification of a cyclin-cdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors
126. Identification of a p130 domain mediating interactions with cyclin A/cdk 2 and cyclin E/cdk 2 complexes
127. Shared role of the pRB-related p130 and p107 proteins in limb development
128. Targeted disruption of p107: Functional overlap between p107 and Rb
129. Mitotic chromosome condensation
130. Structure and function of kinetochores in budding yeast
131. Kinetochores and the checkpoint mechanism that monitors for defects in the chromosome segregation machinery
132. Characterization of a novel 350-kilodalton nuclear phosphoprotein that is specifically involved in mitotic-phase progression
133. HEC, a novel nuclear protein rich in leucine heptad repeats specifically involved in mitosis
134. HEC binds to the seventh regulatory subunit of the 26S proteasome and modulates the proteolysis of mitotic cyclins
135. Retinoblastoma protein enhances the fidelity of chromosome segregation mediated by hsHec1p
136. Hec1p, an evolutionarily conserved coiled-coil protein, modulates chromosome segregation through interaction with SMC proteins
137. Splitting the chromosome: Cutting the ties that bind sister chromatids
138. Sister chromatid cohesion: The beginning of a long and beautiful relationship
139. SMC-mediated chromosome mechanics: A conserved scheme from bacteria to vertebrates?
140. Analysis of the Saccharomyces spindle pole by matrix-assisted laser desorption/ionization (MALDI) mass spectrometry
141. The anaphase-promoting complex: New subunits and regulators
142. S. cerevisiae 26S protease mutants arrest cell division in G2/metaphase
143. Overproduction of Rb protein after the GUS boundary causes G2 arrest
144. p53 and pRb prevent rereplication in response to microtubule inhibitors by mediating a reversible G1 arrest
145. DNA rereplication in the presence of mitotic spindle inhibitors in human and mouse fibroblasts lacking either p53 or pRb function
146. p53 regulation of G(2) checkpoint is retinoblastoma protein dependent
147. The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit
148. Specific enzymatic dephosphorylation of the retinoblastoma protein
149. Regulation of Saccharomyces cerevisiae kinetochores by the type 1 phosphatase Glc7p
150. Defects in Saccharomyces cerevisiae protein phosphatase type 1 activate the spindle/kinetochore checkpoint
151. Effects of p21(Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication
152. Functional interaction between human topoisomerase IIalpha and retinoblastoma protein
153. DNA topoisomerase II is required for condensation and separation of mitotic chromosomes in S. pombe
154. Increased histone H1 phosphorylation and relaxed chromatin structure in Rb-deficient fibroblasts
155. Cancer-susceptibility genes: Gatekeepers and caretakers
156. Cancer: p53, guardian of the genome
157. Mutations in the retinoblastoma-related gene RB2/p130 in primary nasopharyngeal carcinoma
158. Mutations in the retinoblastoma-related gene RB2/p130 in lung tumors and suppression of tumor growth in vivo by retrovirus-mediated gene transfer
159. BRCA1-associated growth arrest is RB-dependent